4-<2-Morpholino-aethoxy>-benzophenon | 102178-03-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-<2-Morpholino-aethoxy>-benzophenon
• 英文别名: 4-[2-(4-Benzoylphenoxy)ethyl]morpholine；[4-(2-morpholin-4-ylethoxy)phenyl]-phenylmethanone
• CAS: 102178-03-0
• 化学式: C₁₉H₂₁NO₃
• 分子量: 311.381
• InChiKey: STEJYNXMCOGTOW-UHFFFAOYSA-N

物化性质

• 熔点：
  83-84 °C
• 沸点：
  479.1±40.0 °C(Predicted)
• 密度：
  1.142±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  38.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-<2-Morpholino-aethoxy>-benzophenon 、 1-苯基-2-丁酮 在 四氯化钛 、 锌 作用下， 以 1,4-二氧六环 为溶剂， 反应 4.0h， 以34%的产率得到2-benzyl-1-phenyl-1-[4-(morpholinylethoxy)phenyl]but-1-ene
  参考文献：
  名称：

  Flexible Estrogen Receptor Modulators:  Design, Synthesis, and Antagonistic Effects in Human MCF-7 Breast Cancer Cells

  摘要：

  Although many series of estrogen receptor antagonists continue to be produced, the majority are direct structural analogues of existing modulators. To examine the tolerance of the estrogen receptor toward flexible ligands, a series of novel flexible estrogen receptor antagonists were prepared and their antiproliferative effects on human MCF-7 breast tumor cells investigated. Each of these compounds deviated from the traditional triphenylethylene backbone associated with common tamoxifen analogues through the introduction of a flexible methylene (benzylic) spacing group between one of the aryl rings and the ethylene group and through variations in the basic side chain moiety. The compounds prepared, when assayed in conjunction with a tamoxifen standard, demonstrated high potency in antiproliferative assays against an MCF-7 human breast cancer cell line with low cytotoxicity and high binding affinity. A computational study was undertaken to investigate the compounds ' potential interactions with specific residues within the human estrogen receptor a ligand-binding domain (ER-LBD), predicting these compounds bind in an antiestrogenic fashion within the ER-LBD and interact with those important residues previously identified in the structures of ER-LBD agonist/antagonist cocrystals. These compounds further illustrate the eclectic nature of the estrogen receptor in terms of ligand flexibility tolerance.

  DOI：

  10.1021/jm001119l
• 作为产物：
  描述：

  N-(2-氯乙基)吗啉盐酸盐 、 4-羟基-二苯甲酮 在 caesium carbonate 作用下， 以 乙腈 为溶剂， 反应 21.0h， 以85%的产率得到4-<2-Morpholino-aethoxy>-benzophenon
  参考文献：
  名称：

  他莫昔芬的三芳基丙烯腈类似物的设计和合成，其与蛋白激酶C的结合选择性提高

  摘要：

  临床选择性雌激素受体调节剂他莫昔芬还是蛋白激酶C的适度抑制剂，该蛋白激酶与多种不可治愈的脑部疾病如苯丙胺滥用有关。这种抑制作用和他莫昔芬穿越血脑屏障的能力使其成为进行进一步的SAR研究以发现针对此类疾病的有效疗法的有吸引力的支架。利用已知化合物6a作为起始模板并在计算工具的指导下获得已知对中枢神经系统渗透性药物重要的理化性质，已经进行了一系列新的三芳基丙烯腈类似物的设计和合成，从而提供了相对于雌激素对PKC具有增强的效力和选择性的化合物相对于他莫昔芬的受体。与经典方法相比，已经开发出缩短的合成路线，以引入β-苯环的类似物，该方法包括先将二烷基氨基烷氧基侧链安装在前体二苯甲酮的α和/或α'环上，然后将所得的酮与苯基乙腈阴离子缩合。还开发了利用铃木化学的第二条新颖，高效且通用的路线，这将允许在丙烯腈核上引入各种各样的β-芳基或β-杂芳基部分和侧链取代基。对于在α-或α'环上具有单侧链的类似物，已进行了新颖的2D

  DOI：

  10.1016/j.bmc.2016.09.002

文献信息

• COMPOSITIONS AND METHODS FOR TREATMENT OF VIRAL DISEASES
  申请人：Johansen Lisa M.

  公开号：US20100009970A1

  公开（公告）日：2010-01-14

  The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E) and the agent or combination of agents includes sertraline, a sertraline analog, UK-416244, or a UK-416244 analog. Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.

  本发明涉及用于治疗病毒性疾病的组合物、方法和试剂盒。在某些实施方式中，病毒性疾病是由单链RNA病毒、黄病毒科病毒或肝病毒引起的。在特定实施方式中，病毒性疾病是病毒性肝炎（例如甲型肝炎、乙型肝炎、丙型肝炎、丁型肝炎、戊型肝炎），药剂或药剂组合包括舍曲林、舍曲林类似物、UK-416244或UK-416244类似物。还包括用于鉴定可用于治疗病毒性疾病的新化合物的筛选方法。
• [EN] COMPOSITIONS AND METHODS FOR TREATING MICROBIAL INFECTIONS<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT D'INFECTIONS MICROBIENNES
  申请人：UNIV VANDERBILT

  公开号：WO2014018925A1

  公开（公告）日：2014-01-30

  Embodiments of the presently-disclosed subject matter include activators of HssRS that induce endogenous heme biosynthesis by perturbing central metabolism. These molecules are toxic to fermenting S. aureus, including clinically relevant small colony variants (SCVs). The utility of targeting fermenting bacteria is exemplified by the fact that this compound prevents the emergence of antibiotic resistance, enhances phagocyte killing, and reduces S. aureus pathogenesis. This small molecule is a powerful tool not only for studying bacterial heme biosynthesis and central metabolism, but also establishes targeting of fermentation as a viable antibacterial strategy.

  目前所披露的主题的实施例包括激活HssRS的活化剂，通过干扰中心代谢诱导内源性血红素生物合成。这些分子对发酵的金黄色葡萄球菌，包括临床相关的小菌落变异体（SCVs）具有毒性。瞄准发酵细菌的实用性可以通过这种化合物防止抗生素耐药性的出现，增强吞噬细胞杀伤力，并减少金黄色葡萄球菌的发病机制。这种小分子不仅是研究细菌血红素生物合成和中心代谢的有力工具，而且还建立了将发酵作为可行抗菌策略的瞄准方式。
• SMALL MOLECULE COMPOUNDS FOR STEM CELL DIFFERENTIATION
  申请人：Mercola Mark

  公开号：US20100159596A1

  公开（公告）日：2010-06-24

  Methods and small molecule compounds for stem cell differentiation are provided. One example of a class of compounds that may be used is represented by the compound having the structure IA or IB in the form of free base or a pharmaceutically acceptable salt, hydrate, solvate or N-oxide thereof: R 1 is independently hydrogen or (C 1 -C 6 )alkyl; R 2 is independently hydrogen, (C 1 -C 6 )alkyl, aryl, or heteroaryl; R 2′ is independently hydrogen, (C 1 -C 6 )alkyl, CF 3 or C 2 F 5 ; R 3 is independently (C 1 -C 6 )alkyl, aryl, 2-tetrahydrofurylmethyl, an aliphatic tertiary amine, or 4-methoxybenzyl; or R 2 and R 3 may be joined together to form a 5 or 6 member ring lactone; R 4 is independently hydrogen, (C 1 -C 6 )alkyl, a 2- or 4-R 5 -substituted aromatic ring selected from a 4-R 5 -phenyl or a 2-R 5 -5-pyridyl, aryl, heteroaryl, aliphatic tertiary amine or halogen; and R 5 , R 5′ , R 6 , R 6′ , R 7 , R 7′ , are each independently hydrogen, (C 1 -C 6 )alkyl, aryl, optionally substituted phenyl, heteroaryl, a heterocyclic ring, an aliphatic tertiary amine, or halogen.

  提供干细胞分化的方法和小分子化合物。可以使用的一类化合物的一个示例由结构IA或IB表示，以自由碱基或其药学上可接受的盐，水合物，溶剂或N-氧化物的形式存在：R1独立地是氢或（C1-C6）烷基; R2独立地是氢，（C1-C6）烷基，芳基或杂环芳基; R2'独立地是氢，（C1-C6）烷基，CF3或C2F5; R3独立地是（C1-C6）烷基，芳基，2-四氢呋喃甲基，脂肪族三级胺或4-甲氧基苄基; 或者R2和R3可以结合形成5或6元环内酯; R4独立地是氢，（C1-C6）烷基，2-或4-R5-取代的芳环，选自4-R5-苯基或2-R5-5-吡啶基，芳基，杂环芳基，脂肪族三级胺或卤素; R5，R5'，R6，R6'，R7，R7'独立地是氢，（C1-C6）烷基，芳基，可选取代的苯基，杂环芳基，杂环环，脂肪族三级胺或卤素。
• Compositions and methods for treatment of viral diseases
  申请人：Johansen Lisa M.

  公开号：US20080161324A1

  公开（公告）日：2008-07-03

  The present invention features compositions, methods, and kits useful in the treatment of viral diseases. In certain embodiments, the viral disease is caused by a single stranded RNA virus, a flaviviridae virus, or a hepatic virus. In particular embodiments, the viral disease is viral hepatitis (e.g., hepatitis A, hepatitis B, hepatitis C, hepatitis D, hepatitis E). Also featured are screening methods for identification of novel compounds that may be used to treat a viral disease.
• COMPOSITIONS AND METHODS FOR TREATING MICROBIAL INFECTIONS
  申请人：Vanderbilt University

  公开号：US20150174130A1

  公开（公告）日：2015-06-25

  Embodiments of the presently-disclosed subject matter include activators of HssRS that induce endogenous heme biosynthesis by perturbing central metabolism. These molecules are toxic to fermenting S. aureus , including clinically relevant small colony variants (SCVs). The utility of targeting fermenting bacteria is exemplified by the fact that this compound prevents the emergence of antibiotic resistance, enhances phagocyte killing, and reduces S. aureus pathogenesis. This small molecule is a powerful tool not only for studying bacterial heme biosynthesis and central metabolism, but also establishes targeting of fermentation as a viable antibacterial strategy.